Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention

Journal of Endocrinology

Volumn 220, Issue 2, 2014, Pages

  Guo, Shaodong ^a,b,c  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR FKHR;

APPETITE; BODY WEIGHT; EDITORIAL; HEART FAILURE; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RESEARCH; REVIEW LITERATURE AS TOPIC; RISK FACTORS;

EID: 84893119342     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0584     Document Type: Editorial

References (10)

1. Alberti KG, Zimmet P & Shaw J 2005 The metabolic syndrome-a new worldwide definition. Lancet 366 1059-1062. (doi:10.1016/S0140-6736(05)67402-8)
2. Cao H 2014 Adipocytokines in obesity and metabolic disease. Journal of Endocrinology 220 T47-T59. (doi:10.1530/JOE-13-0339)
3. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H & Eckel RH 2008 The metabolic syndrome. Endocrine Reviews 29 777-822. (doi:10.1210/er.2008-0024)
4. Guo S 2014 Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms. Journal of Endocrinology 220 T1-T23. (doi:10.1530/JOE-13-0327)
5. Herman WH 2013 The economic costs of diabetes: is it time for a new treatment paradigm? Diabetes Care 36 775-776. (doi:10.2337/dc13-0270)
6. Qi Y, Xu Z, Zhu Q, Thomas C, Kumar R, Feng H, Dostal DE, White MF, Baker KM & Guo S 2013 Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance. Diabetes 62 3887-3900. (doi:10.2337/db13-0095)
7. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES et al. 2011 Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123 e18-e209. (doi:10.1161/CIR.0b013e 3182009701)
8. Schneeberger M, Gomis R & Claret M 2014 Hypothalamic and brainstem neurocircuitries controlling homeostatic energy balance. Journal of Endocrinology 220 T25-T47. (doi:10.1530/JOE-13-0398)
9. Turner N, Cooney GJ, Kraegen EW & Bruce CR 2014 Fatty acid metabolism, energy expenditure and insulin resistance in muscle. Journal of Endocrinology 220 T61-T79. (doi:10.1530/JOE-13-0397)
10. Whiting DR, Guariguata L,Weil C & Shaw J 2011 IDF, diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94 311-321. (doi:10.1016/j.diabres.2011.10.029)